1. Home
  2. DLY vs EMBC Comparison

DLY vs EMBC Comparison

Compare DLY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLY
  • EMBC
  • Stock Information
  • Founded
  • DLY 2019
  • EMBC 1924
  • Country
  • DLY United States
  • EMBC United States
  • Employees
  • DLY N/A
  • EMBC N/A
  • Industry
  • DLY Investment Managers
  • EMBC Medical/Dental Instruments
  • Sector
  • DLY Finance
  • EMBC Health Care
  • Exchange
  • DLY Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • DLY 787.5M
  • EMBC 753.0M
  • IPO Year
  • DLY N/A
  • EMBC N/A
  • Fundamental
  • Price
  • DLY $16.00
  • EMBC $14.62
  • Analyst Decision
  • DLY
  • EMBC Sell
  • Analyst Count
  • DLY 0
  • EMBC 1
  • Target Price
  • DLY N/A
  • EMBC $12.00
  • AVG Volume (30 Days)
  • DLY 215.9K
  • EMBC 247.0K
  • Earning Date
  • DLY 01-01-0001
  • EMBC 11-26-2024
  • Dividend Yield
  • DLY 8.93%
  • EMBC 4.10%
  • EPS Growth
  • DLY N/A
  • EMBC 45.34
  • EPS
  • DLY N/A
  • EMBC 1.20
  • Revenue
  • DLY N/A
  • EMBC $1,118,900,000.00
  • Revenue This Year
  • DLY N/A
  • EMBC $1.45
  • Revenue Next Year
  • DLY N/A
  • EMBC $0.53
  • P/E Ratio
  • DLY N/A
  • EMBC $12.17
  • Revenue Growth
  • DLY N/A
  • EMBC 0.48
  • 52 Week Low
  • DLY $13.26
  • EMBC $9.93
  • 52 Week High
  • DLY $15.95
  • EMBC $19.79
  • Technical
  • Relative Strength Index (RSI)
  • DLY 43.88
  • EMBC 48.99
  • Support Level
  • DLY $16.03
  • EMBC $14.81
  • Resistance Level
  • DLY $16.54
  • EMBC $16.19
  • Average True Range (ATR)
  • DLY 0.20
  • EMBC 0.68
  • MACD
  • DLY 0.02
  • EMBC 0.02
  • Stochastic Oscillator
  • DLY 44.95
  • EMBC 27.69

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is organized as a non-diversified, limited-term, closed-end management investment company. The Fund's investment objective is to seek a high level of total return, with an emphasis on current income.

About EMBC Embecta Corp.

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Share on Social Networks: